Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Introduction

From 1931 to 2025, spanning 94 years, cardiac cancer has remained a rare and sporadic tumor that poses both an investigative dilemma and a therapeutic challenge. Autopsy findings indicate that the incidence of primary cardiac malignancies is approximately 0.02 percent. Surgical resection is considered a viable and often successful treatment option.

Aims

The present study aims to provide an overall assessment of cardiac cancer in Isfahan Province, Iran.

Objectives

To provide detailed information on specific aspects, such as frequency and demographic characteristics of cardiac cancer.

Methods

The representative data of this study were drawn from the general population of Isfahan Province. SEER (Surveillance, Epidemiology, and End Results) data were obtained from the Deputy of Health, Division of Registry of Cancer (between 2011 and 2015). With attention to subject selection (the authors followed the Sex and Gender Equity in Research (SAGER) Guidelines), and according to the ICDO topography code, C38 was considered for further investigation as heart cancer or cardiac tumors.

Results and Discussion

During the study period, a total of 30,465 cancer patients were recorded, comprising 14,638 females and 15,827 males. Among these, 122 cases (0.4 percent) were identified as cardiac cancer, including 42 females and 80 males. The patients' ages ranged from 3 to 95 years, with a mean age of 46.8 ± 21.5 years. The annual distribution of reported cardiac tumors during the study period was as follows: 34, 37, 18, and 33 cases, respectively. Based on available data from the monographic code M, which does not specify subtypes, the following conditions were recorded: mesothelioma ( = 25), neoplasm ( = 11), Hodgkin lymphoma, nodular sclerosis, NOS (n = 14), and other unspecified conditions. A total of three deaths were reported.

Conclusion

In the population studied, the frequency of cardiac cancer in men was significantly higher than in women. Age related to cardiac cancer in 51% was between 40-70 years old. For the patient satisfaction and financial aspects of the Iranian health system, further consideration is suggested regarding referral systems, evidence-based pharmacotherapy, and post-surgery outcome inquiries.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X349291250716112053
2025-07-18
2026-01-28

  • From This Site

    /content/journals/ccr/10.2174/011573403X349291250716112053
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GowdaR.M. KhanI.A. NairC.K. MehtaN.J. VasavadaB.C. SacchiT.J. Cardiac papillary fibroelastoma: A comprehensive analysis of 725 cases.Am. Heart J.2003146340441010.1016/S0002‑8703(03)00249‑7 12947356
     [Google Scholar]
  2. NgaageD.L. MullanyC.J. DalyR.C. Surgical treatment of cardiac papillary fibroelastoma: A single center experience with eighty-eight patients.Ann. Thorac. Surg.20058051712171810.1016/j.athoracsur.2005.04.030 16242444
     [Google Scholar]
  3. Rodriguez ZiccardiM. TariqM.A. LimaiemF. AhmedS.W. Cardiac Cancer.Treasure IslandStatPearls2023
     [Google Scholar]
  4. MkalaluhS. SzczechowiczM. TorabiS. Surgery for cardiac papillary fibroelastoma: A 12-year single institution experience.Med. Sci. Monit. Basic Res.20172325826310.12659/MSMBR.904881 28706178
     [Google Scholar]
  5. ReynenK. Frequency of primary tumors of the heart.Am. J. Cardiol.199677110710.1016/S0002‑9149(97)89149‑7 8540447
     [Google Scholar]
  6. RahoumaM. ArishaM.J. ElmouslyA. Cardiac tumors prevalence and mortality: A systematic review and meta-analysis.Int. J. Surg.20207617818910.1016/j.ijsu.2020.02.039 32169566
     [Google Scholar]
  7. HeS. CaoY. QinW. Prevalence of primary cardiac tumor malignancies in retrospective studies over six decades: A systematic review and meta-analysis.Oncotarget2017826432844329410.18632/oncotarget.17378 28489604
     [Google Scholar]
  8. HabertheuerA. LauferG. WiedemannD. Primary cardiac tumors on the verge of oblivion: A European experience over 15 years.J. Cardiothorac. Surg.20151015610.1186/s13019‑015‑0255‑4 25928192
     [Google Scholar]
  9. LejaM.J. ShahD.J. ReardonM.J. Primary cardiac tumors.Tex. Heart Inst. J.2011383261262 21720466
     [Google Scholar]
  10. SarjeantJ.M. ButanyJ. CusimanoR.J. Cancer of the heart.Am. J. Cardiovasc. Drugs20033640742110.2165/00129784‑200303060‑00004 14728061
     [Google Scholar]
  11. CastilloJ.G. SilvayG. Characterization and management of cardiac tumors.Semin. Cardiothorac. Vasc. Anesth.201014162010.1177/1089253210362596 20472615
     [Google Scholar]
  12. EkmekciE. OzkanB.O. YildizM.S. KocakayaB. Prenatal diagnosis of fetal cardiac rhabdomyoma associated with tuberous sclerosis: A case report.Case Rep. Womens Health201819e0007010.1016/j.crwh.2018.e00070 30094198
     [Google Scholar]
  13. RitterA.L. GranquistE.J. IyerV.R. IzumiK. Cardiac fibroma with ventricular tachycardia: An unusual clinical presentation of nevoid basal cell carcinoma syndrome.Mol. Syndromol.20189421922310.1159/000489056 30140199
     [Google Scholar]
  14. WallsG.M. LyonA.R. HarbinsonM.T. HannaG.G. Cardiotoxicity following cancer treatment.Ulster Med. J.201786139 28298705
     [Google Scholar]
  15. MoradianM. Hejazi ZadehB. Rashidi GhaderF. Primary cardiac tumors in children: An 8-year-experience in a single center.Iran. J. Pediatr.2020306e10886510.5812/ijp.108865
     [Google Scholar]
  16. GhamariZ.T. Prevalence and demographic characteristics of cancers.Clin. Cancer Investig. J.202091318
     [Google Scholar]
  17. MazdakH. Tolou-GhamariZ. Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran.Arab J. Urol.201816220621010.1016/j.aju.2017.11.017 29892483
     [Google Scholar]
  18. Tolou GhamariZ. Prevalence of lung cancer in Isfahan Province, Iran.J. Egypt. Natl. Canc. Inst.2018302575910.1016/j.jnci.2018.03.001 29691096
     [Google Scholar]
  19. Tolou GhamariZ. Prevalence of breast cancer in Isfahan Province, Iran.J. Womens Health2018541410.5812/whb.82678
     [Google Scholar]
  20. GhamariZ.T. Prevalence of stomach cancer in Isfahan Province, Iran.Gulf J. Oncolog.20181284245 30344133
     [Google Scholar]
  21. MazdakH. Tolou GhamariZ. GholampourM. Bladder cancer: Total antioxidant capacity and pharmacotherapy with vitamin-E.Int. Urol. Nephrol.20205271255126010.1007/s11255‑020‑02411‑3 32088809
     [Google Scholar]
  22. Tolou-GhamariZ. Preliminary study of central nervous system tumors’ prevalence and incidence in Isfahan Province Iran.J. Egypt. Natl. Canc. Inst.20203211410.1186/s43046‑020‑00022‑8 32372298
     [Google Scholar]
  23. Tolou GhamariZ. MazdakH. Cancers of urinary system, prevalence, demographic.Urologiia20193167477 32003171
     [Google Scholar]
  24. JoshiM. KumarS. NoshirwaniA. HarkyA. The current management of cardiac tumours: A comprehensive literature review.Rev. Bras. Cir. Cardiovasc.202035577078010.21470/1678‑9741‑2019‑0199 33118743
     [Google Scholar]
  25. PriceS. LandaP. Mujica-MotaR. HamiltonW. SpencerA. Revising the suspected-cancer guidelines: Impacts on patients’ primary care contacts and costs.Value Health2023267995100210.1016/j.jval.2022.06.017 35953398
     [Google Scholar]
  26. RahoumaM. BaudoM. ShmushkevichS. Sex differences in primary malignant cardiac tumors: A multi‐institutional cohort study from National Cancer Database.J. Card. Surg.20223751275128610.1111/jocs.16359 35226369
     [Google Scholar]
  27. SidoV. VolkweinA. HartrumpfM. Gender-related outcomes after surgical resection and level of satisfaction in patients with left atrial tumors.J. Clin. Med.2023125207510.3390/jcm12052075 36902863
     [Google Scholar]
  28. BjessmoS. IvertT. Cardiac myxoma: 40 years’ experience in 63 patients.Ann. Thorac. Surg.199763369770010.1016/S0003‑4975(96)01368‑9 9066386
     [Google Scholar]
  29. TasogluI. TutunU. LafciG. Primary cardiac myxomas: Clinical experience and surgical results in 67 patients.J. Card. Surg.200924325625910.1111/j.1540‑8191.2008.00797.x 19438777
     [Google Scholar]
  30. GodfreyA.K. NaqviS. ChmátalL. Quantitative analysis of Y-chromosome gene expression across 36 human tissues.Genome Res.202030686087310.1101/gr.261248.120 32461223
     [Google Scholar]
  31. OkwuosaT.M. ZahaV.G. Sex differences in cardio-oncology: Considerations for the practicing clinician and researcher.Circulation2022145751051210.1161/CIRCULATIONAHA.122.058906 35157522
     [Google Scholar]
  32. AgaimyA. RöschJ. WeyandM. StreckerT. Primary and metastatic cardiac sarcomas: A 12-year experience at a German heart center.Int. J. Clin. Exp. Pathol.201259928
     [Google Scholar]
  33. KajiharaN. TanoueY. EtoM. TomitaY. MasudaM. MoritaS. Surgical experience of cardiac tumors: Early and late results.Surg. Today200636760260710.1007/s00595‑006‑3217‑6 16794794
     [Google Scholar]
  34. ShukkurA.M. BureslyK.M. UthamanB. Unusual survival time of primary cardiac sarcoma of the right ventricle.Heart Views2011121353810.4103/1995‑705X.81552 21731808
     [Google Scholar]
  35. NazeryI.I. GaemianA. EslamiM. Diagnosis of primary cardiac tumors: Report of 30 cases.Med. J. Islam. Repub. Iran199593197199
     [Google Scholar]
  36. UzunO. WilsonD.G. VujanicG.M. Cardiac tumours in children.Orphanet J. Rare Dis.2007211110.1186/1750‑1172‑2‑11 17331235
     [Google Scholar]
  37. HoffmeierA. SindermannJ.R. ScheldH.H. MartensS. Cardiac tumors--diagnosis and surgical treatment.Dtsch. Arztebl. Int.201411112205211 24717305
     [Google Scholar]
  38. TaoT.Y. Yahyavi-Firouz-AbadiN. SinghG.K. BhallaS. Pediatric cardiac tumors: Clinical and imaging features.Radiographics20143441031104610.1148/rg.344135163 25019440
     [Google Scholar]
  39. BurkeP. TazelaarH. Gomes-RomanJ.J. Benign tumors of pluripotent mesenchym.Pathology and Genetics of Tumours of the Lung. PleuraT. HeartW.T. Lyon, FranceIARC Press2004260265
     [Google Scholar]
  40. StegerC.M. HagerT. RuttmannE. Primary cardiac tumours: A single-center 41-year experience.ISRN Cardiol.201220121710.5402/2012/906109 22792486
     [Google Scholar]
  41. PatelJ. PatelS. SheppardM.N. Benign cardiac tumours associated with sudden death.Europace201416685586010.1093/europace/eut378 24390387
     [Google Scholar]
  42. WilkeP.I. BiermannD. GrafmannM. Siblings with Gorlin–Goltz syndrome associated with cardiac tumors: A case report and review of literature.Orphanet J. Rare Dis.202318117810.1186/s13023‑023‑02792‑5 37408081
     [Google Scholar]
  43. WangZ. ZhangJ. WangJ. In-situ recurrence of cardiac myxoid liposarcoma after surgery.Asian J. Surg.2024Epub ahead of print.10.1016/j.asjsur.2024.08.125
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X349291250716112053
Loading
Cardiac Cancer: An Evidence-Based Study of Occurrence
Curr. Cardiol. Rev. 22, E1573403X349291 (2026); https://doi.org/10.2174/011573403X349291250716112053
/content/journals/ccr/10.2174/011573403X349291250716112053
/content/journals/ccr/10.2174/011573403X349291250716112053
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): cardiac cancer; Frequency; pharmacotherapy; SAGER; SEER; tumors

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test